Observational studyArchives of disease in childhood2023

Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.

Koichi Miyata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.